HIGHLIGHTS
- who: Synthesis et al. from the Laboratory study have published the paper: Received 11/17/2022 Review began 01/13/2023 Review ended 01/28/2023 Published 02/05/2023, in the Journal: (JOURNAL) of February/05,/2023
- what: Study, the author suggests formulating clinically pertinent hypotheses that are investigated through rigorous research. In this study, seven minor compounds with strong trademark resemblance to Cipa were identified, including emetine, anisomycin cycloheximide, homoharringtonine, apicidin, ruxolitinib, and sirolimus. Until now, the focus of research has mostly been on individual herbal preparations, with the main goal being to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.